Trials / Completed
CompletedNCT05512546
The Prevention of Thromboembolic Complications Associated With Coil Embolization
Coil Embolization and Thromboembolic Complications in Patients With Ruptured Aneurysms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Muhammad Hassan · Academic / Other
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspir-Low Pill | patients were prescribed 75 mg/day of either aspirin |
Timeline
- Start date
- 2017-02-10
- Primary completion
- 2020-02-10
- Completion
- 2020-12-10
- First posted
- 2022-08-23
- Last updated
- 2022-08-23
Locations
1 site across 1 country: Pakistan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05512546. Inclusion in this directory is not an endorsement.